Geode Capital Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,080,275 shares of ALNY stock, worth $572 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,080,275

Previous 2,001,718 3.92%

Holding current value

$572 Million

Previous $299 Million 68.98%

% of portfolio

0.04%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$143.31 - $247.0 $11.3 Million - $19.4 Million	78,557 Added 3.92%	2,080,275 $506 Million
Q1 2024 May 13, 2024	BUY	$146.51 - $198.2 $11 Million - $14.9 Million	74,982 Added 3.89%	2,001,718 $299 Million
Q4 2023 Feb 13, 2024	BUY	$151.41 - $196.57 $13.2 Million - $17.1 Million	87,231 Added 4.74%	1,926,736 $369 Million
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $6.4 Million - $7.93 Million	37,483 Added 2.08%	1,839,505 $326 Million
Q2 2023 Aug 11, 2023	BUY	$185.01 - $212.05 $11.8 Million - $13.6 Million	63,907 Added 3.68%	1,802,022 $342 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $8.8 Million - $11.3 Million	48,186 Added 2.85%	1,738,115 $348 Million
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $16.8 Million - $21.8 Million	90,455 Added 5.66%	1,689,929 $401 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $3.71 Million - $6.21 Million	26,771 Added 1.7%	1,599,474 $320 Million
Q2 2022 Aug 12, 2022	BUY	$120.42 - $169.29 $291,416 - $409,681	2,420 Added 0.15%	1,572,703 $229 Million
Q1 2022 May 13, 2022	BUY	$127.18 - $173.91 $8.27 Million - $11.3 Million	64,992 Added 4.32%	1,570,283 $256 Million
Q4 2021 Feb 11, 2022	BUY	$159.56 - $209.29 $8.18 Million - $10.7 Million	51,272 Added 3.53%	1,505,291 $255 Million
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $1.36 Million - $1.66 Million	8,001 Added 0.55%	1,454,019 $274 Million
Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $7.68 Million - $10.6 Million	59,719 Added 4.31%	1,446,018 $245 Million
Q1 2021 May 12, 2021	BUY	$126.83 - $175.69 $9.79 Million - $13.6 Million	77,166 Added 5.89%	1,386,299 $195 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $6.07 Million - $7.25 Million	49,330 Added 3.92%	1,309,133 $170 Million
Q3 2020 Nov 13, 2020	SELL	$121.19 - $165.49 $2.97 Million - $4.05 Million	-24,493 Reduced 1.91%	1,259,803 $183 Million
Q2 2020 Aug 13, 2020	SELL	$104.21 - $156.44 $7.26 Million - $10.9 Million	-69,632 Reduced 5.14%	1,284,296 $190 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $10.7 Million - $15.3 Million	114,441 Added 9.23%	1,353,928 $147 Million
Q4 2019 Feb 13, 2020	BUY	$74.51 - $124.23 $3.78 Million - $6.31 Million	50,788 Added 4.27%	1,239,487 $143 Million
Q3 2019 Nov 12, 2019	BUY	$70.9 - $87.82 $9.11 Million - $11.3 Million	128,504 Added 12.12%	1,188,699 $95.5 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $3.55 Million - $5.01 Million	53,973 Added 5.36%	1,060,195 $76.9 Million
Q1 2019 May 14, 2019	BUY	$72.76 - $93.45 $6.6 Million - $8.47 Million	90,689 Added 9.91%	1,006,222 $94 Million
Q4 2018 Feb 13, 2019	BUY	$62.67 - $88.33 $2.18 Million - $3.07 Million	34,770 Added 3.95%	915,533 $66.7 Million
Q3 2018 Nov 13, 2018	BUY	$87.52 - $122.67 $6.48 Million - $9.08 Million	74,018 Added 9.17%	880,763 $77 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $3.66 Million - $4.46 Million	41,401 Added 5.41%	806,745 $79.4 Million
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $2.05 Million - $2.63 Million	17,698 Added 2.37%	765,344 $91.1 Million
Q4 2017 Feb 13, 2018	BUY	$114.49 - $139.98 $10.1 Million - $12.3 Million	88,119 Added 13.36%	747,646 $94.9 Million
Q3 2017 Nov 14, 2017	SELL	$72.53 - $118.27 $208,741 - $340,381	-2,878 Reduced 0.43%	659,527 $77.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	662,405	662,405 $52.8 Million

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History